10.1016/j.berh.2023.101852 116 Morales-IvorraI.Romera-BauresM.Roman-ViasB.Serra-MajemL
insert the needle at 90 (or 45 if very little subcutaneous fat) into subcutaneous tissue [7]
The bottom line The mainstreaming of GLP-1 medications has legitimized patient interest in a broader class of therapies that most people knew nothing about five years ago
Phaniendra A, Jestadi DB, Periyasamy L
In addition to its fat-burning properties, CLA is recognized for its ability to help maintain normal blood cholesterol levels, supporting cardiovascular health
Both medications note the risk of delayed gastric emptying, among other stomach problems such as nausea, vomiting, and diarrhea, but do not include an explicit warning of gastroparesis